Contact Us

GENTAUR Europe

 GENTAUR Europe BVBA
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45 
Fax 0032 16 50 90 45
This email address is being protected from spambots. You need JavaScript enabled to view it.">This email address is being protected from spambots. You need JavaScript enabled to view it. 

Gentaur Bulgaria

 GENTAUR BULGARIA
53 Iskar Str. 1191 Kokalyane, Sofia
Tel 0035924682280 
Fax 0035929830072
This email address is being protected from spambots. You need JavaScript enabled to view it." style="">This email address is being protected from spambots. You need JavaScript enabled to view it.

    GENTAUR France

     GENTAUR France SARL
    9, rue Lagrange, 75005 Paris 
    Tel 01 43 25 01 50 
    Fax 01 43 25 01 60
    This email address is being protected from spambots. You need JavaScript enabled to view it." style="">This email address is being protected from spambots. You need JavaScript enabled to view it.
    This email address is being protected from spambots. You need JavaScript enabled to view it." style="">This email address is being protected from spambots. You need JavaScript enabled to view it.

    Gentaur Germany

    This email address is being protected from spambots. You need JavaScript enabled to view it." style="font-size: 12px; line-height: 1.3em;">

      GmbH Marienbongard 20
    52062 Aachen Deutschland
    Tel (+49) 0241 56 00 99 68 
    Fax (+49) 0241 56 00 47 88 This email address is being protected from spambots. You need JavaScript enabled to view it." style="font-family: Arial, Tahoma, Verdana, Helvetica; line-height: 15.59375px; ">
    This email address is being protected from spambots. You need JavaScript enabled to view it." style="">This email address is being protected from spambots. You need JavaScript enabled to view it.

    This email address is being protected from spambots. You need JavaScript enabled to view it." style="font-size: 12px; line-height: 1.3em;">

    This email address is being protected from spambots. You need JavaScript enabled to view it." style="">This email address is being protected from spambots. You need JavaScript enabled to view it.

    This email address is being protected from spambots. You need JavaScript enabled to view it.

    Gentaur London

     GENTAUR Ltd. 
    Howard Frank Turnberry House 
    1404-1410 High Road 
    Whetstone London N20 9BH 
    Tel 020 3393 8531 
    Fax 020 8445 9411
    This email address is being protected from spambots. You need JavaScript enabled to view it." style="">This email address is being protected from spambots. You need JavaScript enabled to view it.

    GENTAUR Poland

     GENTAUR Poland Sp. z o.o. 

    ul. Grunwaldzka 88/A m.2

    81-771 Sopot, Poland
    Tel  058 710 33 44
    Fax 058 710 33 48 
    This email address is being protected from spambots. You need JavaScript enabled to view it." style="">This email address is being protected from spambots. You need JavaScript enabled to view it.

    GENTAUR Nederland

     GENTAUR Nederland BV
    Kuiper 1 
    5521 DG Eersel Nederland
    Tel 0208-080893 
    Fax 0497-517897
    This email address is being protected from spambots. You need JavaScript enabled to view it." style="">This email address is being protected from spambots. You need JavaScript enabled to view it.

    Gentaur Italy

     GENTAUR SRL IVA IT03841300167

    Piazza Giacomo Matteotti, 6, 24122 Bergamo
    Tel 02 36 00 65 93 
    Fax 02 36 00 65 94
    This email address is being protected from spambots. You need JavaScript enabled to view it.">This email address is being protected from spambots. You need JavaScript enabled to view it.

    GENTAUR Spain

     GENTAUR Spain
    Tel 0911876558
    This email address is being protected from spambots. You need JavaScript enabled to view it." style="">This email address is being protected from spambots. You need JavaScript enabled to view it.

    Genprice USA

    usa-flagGenprice Inc, Logistics
    547, Yurok Circle
    San Jose, CA 95123
    Phone/Fax: 

    (408) 780-0908 

    This email address is being protected from spambots. You need JavaScript enabled to view it.

    skype chat

    GENPRICE Inc. invoicing/ accounting:
    6017 Snell Ave, Suite 357
    San Jose, CA. 96123

     

    Gentaur Serbia

    serbiaSerbia, Macedonia FlagMacedonia, 

    montenegro-flagMontenegro, croatiaCroatia: 
    Tel 0035929830070 
    Fax 0035929830072
    This email address is being protected from spambots. You need JavaScript enabled to view it.">This email address is being protected from spambots. You need JavaScript enabled to view it.

    GENTAUR Romania

    romGENTAUR Romania

    Tel 0035929830070 
    Fax 0035929830072
    This email address is being protected from spambots. You need JavaScript enabled to view it.">This email address is being protected from spambots. You need JavaScript enabled to view it.

    GENTAUR Greece

    grGENTAUR Greece 

    Tel 00302111768494 
    Fax 0032 16 50 90 45

    This email address is being protected from spambots. You need JavaScript enabled to view it.">This email address is being protected from spambots. You need JavaScript enabled to view it.

    Other countries

    Other countries
    Luxembourg +35220880274
    Schweiz Züri +41435006251
    Danmark +4569918806
    Österreich +43720880899
    Ceská republika Praha +420246019719
    Ireland Dublin +35316526556
    Norge Oslo +4721031366
    Finland Helsset +358942419041
    Sverige Stockholm +46852503438
    Magyarország Budapest +3619980547

    seal-in-search-symantec

     

     

    avian-flu-body-formation-snl-feeder-pluripotency-marker-cf-1-gene-knock-in-technology-ipsc-generationThese laboratory studies have opponents, there is no guarantee that nature will follow the theoretical approach.

    While some scholars argue that it should be kept for research purposes genetically manipulated viruses of avian influenza in several laboratories around the world are already conducting similar experiments, reported the German magazine "Focus". Several teams working in parallel with genetically manipulated virus H7N9. Ron Fucino, one of the scientists involved in the experiments confirmed that his colleagues in several places around the world already are testing resistance to drugs.

    Other attempts were allegedly in the pipeline, says Fucino who specializes Flu Medical Center "Erasmus" in Rotterdam. They will study the behavior of the virus modified so as to be easily transmitted from person to person. From mid-March in China already has at least 130 people infected with the dangerous strain H7N9.

    This week leading experts called in the journal "Nature" to be carried out similar experiments in which the causative agent is modified in vitro so as to be more infectious and resistant to treatment with drugs. They hope that science will overtake both real life and will be prepared to respond to any mutations in the strain of bird flu, which has threatened a number of Asian countries.

    Such an approach, however, meeting and much criticism. According to the China Center for combating infectious diseases in natural mutation of a virus can take years. In the laboratory, it happened in an instant. There is no guarantee that the actual mutations will follow artificial scientific model.

    According to Ron Fucino however scientific experiments are very useful and are based on actual forecasts. Attempts would make it possible to produce more effective vaccines and scientific teams would predict risks of transmission of the virus from person to person. New form of H7N9 bird flu was confirmed in humans for the first time in March 2013 Health officials believe that spillover occurred from birds to humans. Thousands of birds were killed and live poultry markets were closed. An outcome measure, the number of new infected dropped almost to zero. In April, the WHO issued a warning that in some cases the virus can be passed from person to person. Scientists from China have joined this opinion and wrote in the British Medical Journal, the risk of bird flu is by no means

    Published in News

    bird-flu-rosa26-feeder-cells-human-primary-cells-mef cells-rat-knock-out-stem-cellDeadly H7N9 occurs for the first time in March

    Chinese scientists have found the most convincing evidence so far that the deadly new strain of bird flu, "jump" from person to person. Experts emphasize, however, that the virus still can not be easily transmitted between humans, BTA reported.

    The first scientific analysis of the transmission of the strain H7N9, showed for the first time in China in March this year, is published in the journal "British Medical Journal".
    The study analyzed the case of a father and daughter from East China died after infection with H7N9. Experts have not been able to talk to them since they were both in serious condition, but questioned the family members and loved ones
    friends. The analysis has shown that it is highly likely that the virus will be transmitted directly from the 60-year-old man, his daughter.

    In a commentary accompanying the publication, experts note that "the study does not necessarily mean that H7N9 will be the next culprit an influenza pandemic, but stresses the need for extreme vigilance."
    "The threat, which is H7N9, does not over," commented James Radzh and Richard Coker of the London School of Hygiene and Tropical Medicine.

    The authors of this study from the Centre for prevention and control of diseases in Jiangsu province, however, stressed that the new strain has not yet acquired the ability to transmit efficiently from person to person. This means that the risk of the virus in its current form can cause human pandemic is very low.

    The new H7N9 strain of bird flu occurs in March in China. According to WHO, the virus has so far infected 133 people in the country and Taiwan, killing 43 of them. Most cases of infection among people who have visited markets for live birds or had close contact with live birds between seven and 10 days to get sick.

    The study, published in the journal "British Medical Journal" analyzed "family" case of two patients - a father and daughter from East China. 60-year-old man regularly visited the market for live poultry and got sick between five and six days after the last contact with birds. He was admitted to hospital on March 11. Following the deterioration of symptoms the patient was transferred to the intensive ward on March 15. He died of multiple organ failure on May 4.

    The second patient - his healthy 32-year-old daughter, not having visited markets for poultry, but has been in direct contact with his father, caring for him in the hospital before his transfer to the ICU. The woman developed symptoms of infection
    six days after the last contact with his father. Admitted to the hospital on March 24, moved in ICU on March 28 and died of multiple organ failure on April 24.

    Strains of the virus isolated from samples of both patients were "almost genetically identical" - convincing evidence that H7N9 has passed directly from father to daughter.

    "To our knowledge, this is the first report of a possible transmission of the new virus from person to person, accompanied by detailed epidemiological, clinical and virological data," wrote the authors of the study published in the journal "British Medical Journal".

    Published in News
    Monday, 08 April 2013 10:14

    Avian influenza H7N9 Promo

    uscn smallDear Clients, 

    We are happy to announce that another promo is available as of today: 

    1. Intended Use 

    Avian influenza virus H7N9 real time RT-PCR kit is used for the detection of gene H7 and gene N9 of avian influenza A subtype H7N9 in human nasal and pharyngeal secretions and bird fece by using real time PCR systems.

    2. Principle of Real-Time PCR

    The principle of the real-time detection is based on the fluorogenic 5’nuclease assay. During the PCR reaction, the DNA polymerase cleaves the probe at the 5’ end and separates the reporter dye from the quencher dye only when the probe hybridizes to the target DNA. This cleavage results in the fluorescent signal generated by the cleaved reporter dye, which is monitored real-time by the PCR detection system. The PCR cycle at which an increase in the fluorescence signal is detected initially (Ct) is proportional to the amount of the specific PCR product. Monitoring the fluorescence intensities during Real Time allows the detection of the accumulating product without having to re-open the reaction tube after the amplification.

    3. Product Description

    Highly pathogenic avian influenza (HPAI) caused by certain subtypes of influenza A virus in animal populations, particularly chickens, poses a continuing global human public health risk. Direct human infection by an avian influenza A (H5N1) virus was first recognized during the 1997 outbreak in Hong Kong. The avian influenza virus H7N9 is one subgroup among the larger group of H7 viruses. Some cases of human infection with H7N9 virus in China are confirmed till early April of 2013.

    Avian influenza virus H7N9 real time RT-PCR kit contains a specific ready-to-use system for the detection of avian influenza virus H7N9 by Reverse Transcription Polymerase Chain Reaction (RT-PCR) in the real-time PCR system. The master contains Super Mix for the specific amplification of the avian influenza virus H7N9 RNA. The reaction is done in one step real time RT-PCR. The first step is a reverse transcription (RT), during which the avian influenza virus H9 RNA is transcribed into cDNA. Afterwards, a thermostable DNA polymerase is used to amplify the specific gene fragments by polymerase chain reaction. Fluorescence is emitted and measured by the real time systems´ optical unit during the PCR. The detection of amplified avian influenza virus H7N9 DNA fragment is performed in fluorimeter channel FAM and HEX/VIC/JOE with the fluorescent quencher BHQ1. In addition, the kit contains a system to identify possible PCR inhibition by measuring the FAM fluorescence of the internal control (IC).

     4. Kit Contents

    Ref.

    Type of reagent

    Presentation 25rxns

    1

    2

    3

    4

    H7N9 Super Mix

    RT-PCR Enzyme Mix

    Molecular Grade Water

    H7N9 Positive Control  

    1 vial, 480ml

    1 vial, 28ml

    1 vial, 400μl

    1 vial, 30μl

    Analysis sensitivity: 1×103copies/ml;

    Note: Analysis sensitivity depends on the sample volume, elution volume, nucleic acid extraction methods and other factors .If you use the RNA extraction kits recommended, the analysis sensitivity is the same as it declares. However, when the sample volume is dozens or even hundreds of times greater than elution volume by some concentrating method, it can be much.

     

    Our Price: EUR 562

    Order Button1

     

    For additional information, here is a full view of Gentaur's AIV-related products: 

    http://antibody-antibodies.com/search_full.php?search=AIV

    Published in Promos